Semaglutide 2.4 mg once a week decreases bodyweight in overweight or obese patients with type 2 diabetes
1. Change in mean bodyweight was -9.6% with semaglutide 2.4 mg vs. -3.4% with placebo. 2. Approximately two-thirds of patients ...
1. Change in mean bodyweight was -9.6% with semaglutide 2.4 mg vs. -3.4% with placebo. 2. Approximately two-thirds of patients ...
1. Once-weekly treatment of semaglutide was associated with meaningful body weight reduction at 68 weeks compared to placebo in patients ...
1. For older adults with overweight or obesity, and metabolic syndrome, replacing 30 minutes of inactive time with moderate to ...
1. Children with obesity were at greater risk of mortality in early adulthood than a population-based comparison group, suggesting that ...
1. In this study of family-based intervention for childhood obesity, a specialized intervention incorporating social facilitation and behavioral skills was ...
1. In patients with coronary artery disease (CAD), increased body-weight variability demonstrated a graded increased risk of cardiovascular events and ...
1. Maximum BMIs in overweight, obese, and obese II categories were associated with increases in risk for all-cause mortality. 2. ...
1. All racial/ethnic minority groups evaluated, compared with Caucasian patients, had a statistically higher prevalence of metabolic abnormality but normal ...
1. After 56 weeks of a weight maintenance intervention program, researchers found that mean weight regain in the intervention group ...
1. Among 2.3 million individuals (42.3 million patient years of follow-up), in those who had a BMI in the mid-normal ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.